Back
Protagonist Therapeutics Stock Price Chart
2025 Gold Forecast: A Perfect Storm for Demand
Discover our Gold Price Outlook for 2025--FREE--here
Sell
47
PTGX
Protagonist Therapeutics
Last Price:
$39.25
Seasonality Move:
28.98%
7 Day Trial
ALL ACCESS PASS
$
7
Elon Musk Predicts MAJOR Crisis in Trump's First Year
See Why Investors are Pouring Mountains of Cash into Certain Companies Trump Wants to Solve the Problem.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PTGX is experiencing slight selling pressure.
Protagonist Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 40.54 | Buy |
| 20-day SMA: | 41.77 | Sell |
| 50-day SMA: | 43.9 | Sell |
| 200-day SMA: | 37.06 | Buy |
| 8-day EMA: | 40.67 | Sell |
| 20-day EMA: | 41.46 | Sell |
| 50-day EMA: | 42.61 | Sell |
| 200-day EMA: | 37.75 | Buy |
Protagonist Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.93 | Sell |
| Relative Strength Index (14 RSI): | 45.14 | Sell |
| Chaikin Money Flow: | -91934 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (39.76 - 43.68) | Sell |
| Bollinger Bands (100): | (40.26 - 46.26) | Sell |
Protagonist Therapeutics Technical Analysis
| Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 23 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | 23 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Protagonist Therapeutics Stock
Is Protagonist Therapeutics Stock a Buy?
-
Protagonist Therapeutics share price is 40.60 while PTGX 8-day simple moving average is 40.54, which is a Buy signal.
-
The stock price of PTGX is 40.60 while Protagonist Therapeutics 20-day SMA is 41.77, which makes it a Sell.
-
Protagonist Therapeutics 50-day simple moving average is 43.90 while PTGX share price is 40.60, making it a Sell technically.
-
PTGX stock price is 40.60 and Protagonist Therapeutics 200-day simple moving average is 37.06, creating a Buy signal.
PTGX Technical Analysis vs Fundamental Analysis
Sell
47
Protagonist Therapeutics (PTGX)
is a Sell
Is Protagonist Therapeutics a Buy or a Sell?
-
Protagonist Therapeutics stock is rated a SellThe current Protagonist Therapeutics [PTGX] share price is $40.60. The Score for PTGX is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
Protagonist Therapeutics Stock Info
Market Cap:
2.4B
Price in USD:
40.60
Share Volume:
764K
Protagonist Therapeutics 52-Week Range
52-Week High:
48.89
52-Week Low:
21.43
Sell
47
Protagonist Therapeutics (PTGX)
is a Sell
Protagonist Therapeutics Share Price Forecast
-
What is the Protagonist Therapeutics stock price today?The Protagonist Therapeutics stock price is 40.60 USD today.
-
Will PTGX stock go up or go down?Protagonist Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Protagonist Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Protagonist Therapeutics is overvalued.
Is Protagonist Therapeutics Stock a Buy?
-
Protagonist Therapeutics share price is 40.60 while PTGX 8-day exponential moving average is 40.67, which is a Sell signal.
-
The stock price of PTGX is 40.60 while Protagonist Therapeutics 20-day EMA is 41.46, which makes it a Sell.
-
Protagonist Therapeutics 50-day exponential moving average is 42.61 while PTGX share price is 40.60, making it a Sell technically.
-
PTGX stock price is 40.60 and Protagonist Therapeutics 200-day simple moving average is 37.75, creating a Buy signal.
Fundamental Analysis of Protagonist Therapeutics
Is Protagonist Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.57 per share, and a decrease next year of $3.76 per share.
Technical Analysis of Protagonist Therapeutics
Should I short Protagonist Therapeutics stock?
-
PTGX Moving Average Covergence Divergence (MACD) indicator is -0.93, suggesting Protagonist Therapeutics is a Sell
-
Protagonist Therapeutics Relative Strength Index (RSI) is 45.14, which suggest Protagonist Therapeutics is oversold
-
The Bollinger Bands (25) for Protagonist Therapeutics is (39.76 - 43.68), which suggest Protagonist Therapeutics is a Sell
-
The Bollinger Bands (100) for Protagonist Therapeutics is (40.26 - 46.26), which suggest Protagonist Therapeutics is a Sell
* Protagonist Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.